diclofenac has been researched along with Eosinophilia in 4 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The degree of local eosinophilia was significantly and positively correlated with the changes in IL-5 production induced by diclofenac treatment." | 3.75 | Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps. ( Fujiwara, T; Haruna, T; Higaki, T; Kariya, S; Makihara, S; Nishizaki, K; Okano, M, 2009) |
| "The diclofenac therapy was discontinued." | 1.32 | [Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient]. ( Geiger, D; Häussinger, K; Kohlhäufl, M; Morresi-Hauf, A; Raith, H; Weber, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charfi, O | 1 |
| Aouinti, I | 1 |
| Zaiem, A | 1 |
| Lakhoua, G | 1 |
| El Aidli, S | 1 |
| Kastalli, S | 1 |
| Okano, M | 1 |
| Fujiwara, T | 1 |
| Haruna, T | 1 |
| Kariya, S | 1 |
| Makihara, S | 1 |
| Higaki, T | 1 |
| Nishizaki, K | 1 |
| Kohlhäufl, M | 1 |
| Weber, N | 1 |
| Morresi-Hauf, A | 1 |
| Geiger, D | 1 |
| Raith, H | 1 |
| Häussinger, K | 1 |
| Vereerstraeten, P | 1 |
| Thoua, Y | 1 |
| Goldman, M | 1 |
| Schandene, L | 1 |
| Vanherweghem, JL | 1 |
| Toussaint, C | 1 |
4 other studies available for diclofenac and Eosinophilia
| Article | Year |
|---|---|
Diclofenac induced drug rash with eosinophilia and systemic symptoms.
Topics: Diclofenac; Drug Eruptions; Drug Hypersensitivity Syndrome; Eosinophilia; Female; Humans; Middle Age | 2018 |
Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps.
Topics: Adult; Aged; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines; Diclofenac; Dinoprostone; Entero | 2009 |
[Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cough; Diclofenac | 2003 |
[Reversible nephrotic syndrome and acute renal failure associated with alclofenac administration].
Topics: Acute Kidney Injury; Diclofenac; Eosinophilia; Humans; Kidney; Male; Middle Aged; Nephrotic Syndrome | 1982 |